Published on 15 Sep 2021 on Benzinga via Yahoo Finance
FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results.BELLUS Health Inc. (NASDAQ: BLU) shares climbed 25.5% to $6.00. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic cough. HC Wainwright on Tuesday raised its price target on the stock.BTCS Inc. (NASDAQ: BTCS) shares climbed 23% to $10.25 as the company commenced trading on The Nasdaq Capital Market.Communications Systems, Inc. (NASDAQ: JCS) gained 22.3% to $8.25 as the company declared a special dividend of $3.50 per share.aTyr Pharma, Inc. (NASDAQ: LIFE) shares jumped 22.3% to $11.19 after multiple firms maintained bullish ratings on the stock and raised their respective price targets. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.DatChat, Inc. (NASDAQ: DATS) rose 22.2% to $7.99 after gaining around 4% on Monday.Onion Global Limited (NYSE: OG) gained 17.3% to $6.55 after dropping 18% on Monday.NanoViricides, Inc. (NYSE: NNVC) rose 17.2% to $4.7706 after the company announced it completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc.Gulf Resources, Inc. (NASDAQ: GURE) gained 16.4% to $4.84. Gulf Resources said it sees Q3 revenue of $16.2 million to $16.7 million.Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) rose 16.2% to $1.2205. Matinas BioPharma shares climbed 27% on Monday after the company announced data in the ongoing EnACT trial of MAT2203 for treatment of Cryptococcal Meningitis.AzurRx BioPharma, Inc. (NASDAQ: AZRX) gained 15.9% to $4.75 after the company announced acquisition of First Wave Bio for $229 million in stock and cash.Calumet Specialty Products Partners, L.P., (NASDAQ: CLMT) surged 14% to $7.00 after declining 20% on Monday.Jounce Therapeutics, Inc. (NASDAQ: JNCE) surged 13.8%to $7.36 Raymond James upgraded Jounce Therapeutics from Market Perform to Outperform and announced a $10 price target.Alset EHome International Inc. (NASDAQ: AEI) gained 9.1% to $3.0999. The company recently announced the completion of a subscription agreement with Document Security Systems.Cyren Ltd. (NASDAQ: CYRN) rose 8.6% to $0.6310 after the company reported a distribution agreement with TD SYNNEX to offer its anti-phishing solution throughout North America.Angi Inc. (NASDAQ: ANGI) gained 8.3% to $11.59. IAC posted monthly metrics for August 2021, including metrics for Angi Inc, in the investor relations section of the IAC website.Oscar Health, Inc. (NYSE: OSCR) rose 7% to $18.30. Oscar Health Co-Founder Joshua Kushner reported the purchase of 1,072,264 shares at an average price of $17.41 per share in Form 4 Filing.Akerna Corp. (NASDAQ: KERN) rose 6.3% to $3.5199. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal.EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) rose 6.3% to $1.7850. EyeGate Pharma recently completed target enrollment in Phase 2 proof-of-concept study to evaluate PP-001 for the treatment of ocular surface inflammation.NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) rose 5% to $11.53 after IQVIA announced a collaboration with the company on potential medical support for novel COVID-19 treatment.
Start tracking your investments with StatfolioSign up for free